Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 22 | 2024 | 3863 | 1.420 |
Why?
|
| Hydrocephalus | 3 | 2024 | 276 | 0.970 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2024 | 51 | 0.930 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 42 | 0.770 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 359 | 0.670 |
Why?
|
| Pons | 2 | 2024 | 35 | 0.580 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 60 | 0.550 |
Why?
|
| Contrast Media | 6 | 2022 | 517 | 0.510 |
Why?
|
| Societies, Medical | 6 | 2022 | 779 | 0.480 |
Why?
|
| Neck Injuries | 1 | 2014 | 24 | 0.430 |
Why?
|
| Angiography | 1 | 2014 | 215 | 0.410 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 84 | 0.410 |
Why?
|
| Child | 29 | 2024 | 25843 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 616 | 0.390 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2015 | 359 | 0.390 |
Why?
|
| Brain Stem | 2 | 2022 | 119 | 0.380 |
Why?
|
| White Matter | 1 | 2015 | 212 | 0.380 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 225 | 0.370 |
Why?
|
| Vestibular Nerve | 1 | 2011 | 8 | 0.360 |
Why?
|
| Neuroimaging | 7 | 2023 | 376 | 0.360 |
Why?
|
| Brain | 5 | 2023 | 3224 | 0.340 |
Why?
|
| Nervous System Malformations | 1 | 2011 | 132 | 0.320 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 159 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2022 | 2193 | 0.300 |
Why?
|
| Diagnosis, Differential | 9 | 2025 | 1965 | 0.300 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 139 | 0.290 |
Why?
|
| Evidence-Based Medicine | 6 | 2022 | 679 | 0.290 |
Why?
|
| Sinusitis | 2 | 2020 | 114 | 0.290 |
Why?
|
| Humans | 45 | 2025 | 133269 | 0.280 |
Why?
|
| Epilepsy | 1 | 2015 | 897 | 0.280 |
Why?
|
| Inflammation | 1 | 2015 | 1557 | 0.260 |
Why?
|
| Pediatrics | 1 | 2015 | 1220 | 0.250 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 1163 | 0.250 |
Why?
|
| Retrospective Studies | 14 | 2024 | 17554 | 0.240 |
Why?
|
| Demyelinating Diseases | 2 | 2018 | 71 | 0.240 |
Why?
|
| Infant | 12 | 2024 | 13230 | 0.240 |
Why?
|
| Seizures | 3 | 2025 | 889 | 0.230 |
Why?
|
| Cranial Nerves | 1 | 2024 | 20 | 0.230 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 1406 | 0.220 |
Why?
|
| Skull | 2 | 2022 | 145 | 0.220 |
Why?
|
| Skull Base | 1 | 2024 | 52 | 0.210 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 9 | 0.210 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.210 |
Why?
|
| Actinomycetaceae | 1 | 2023 | 6 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 8 | 0.210 |
Why?
|
| Actinomycosis | 1 | 2023 | 8 | 0.210 |
Why?
|
| Hysterotomy | 1 | 2024 | 127 | 0.210 |
Why?
|
| Empyema | 1 | 2023 | 24 | 0.210 |
Why?
|
| Laparotomy | 1 | 2024 | 143 | 0.210 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 28 | 0.210 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2003 | 22 | 0.210 |
Why?
|
| Child, Preschool | 13 | 2025 | 14859 | 0.200 |
Why?
|
| Globus Pallidus | 1 | 2003 | 69 | 0.200 |
Why?
|
| Basal Ganglia | 1 | 2003 | 64 | 0.200 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 317 | 0.200 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 52 | 0.200 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1887 | 0.200 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 72 | 0.200 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 35 | 0.200 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 10 | 0.190 |
Why?
|
| Survivorship | 1 | 2022 | 44 | 0.190 |
Why?
|
| Female | 21 | 2025 | 71454 | 0.190 |
Why?
|
| Tinnitus | 1 | 2022 | 23 | 0.190 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 69 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 252 | 0.180 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 34 | 0.180 |
Why?
|
| Anemia | 1 | 2025 | 349 | 0.180 |
Why?
|
| Scalp | 1 | 2021 | 58 | 0.180 |
Why?
|
| Meningomyelocele | 1 | 2024 | 255 | 0.180 |
Why?
|
| Prognosis | 3 | 2024 | 5042 | 0.180 |
Why?
|
| Proton Therapy | 1 | 2022 | 151 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2022 | 245 | 0.170 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 19 | 0.170 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.170 |
Why?
|
| Fetoscopy | 1 | 2024 | 449 | 0.170 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 248 | 0.160 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 151 | 0.160 |
Why?
|
| Male | 20 | 2025 | 65527 | 0.160 |
Why?
|
| Hematoma, Subdural | 1 | 2019 | 25 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 276 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 54 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 124 | 0.160 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8628 | 0.150 |
Why?
|
| Spinal Injuries | 1 | 2019 | 34 | 0.150 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2018 | 11 | 0.150 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 154 | 0.150 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 12 | 0.150 |
Why?
|
| Temporal Bone | 2 | 2018 | 37 | 0.150 |
Why?
|
| Myelitis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cochlea | 1 | 2018 | 90 | 0.140 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 52 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2003 | 717 | 0.140 |
Why?
|
| Polyneuropathies | 1 | 2018 | 32 | 0.140 |
Why?
|
| Ipilimumab | 1 | 2018 | 61 | 0.140 |
Why?
|
| West Nile virus | 1 | 2018 | 117 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 373 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.130 |
Why?
|
| Child Abuse | 1 | 2019 | 203 | 0.130 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 128 | 0.130 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 13 | 0.130 |
Why?
|
| Pregnancy | 3 | 2024 | 7596 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 411 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 664 | 0.120 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 8 | 0.120 |
Why?
|
| Transverse Sinuses | 1 | 2014 | 1 | 0.110 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 395 | 0.110 |
Why?
|
| Hearing Aids | 1 | 2014 | 32 | 0.110 |
Why?
|
| Vertebral Artery | 1 | 2014 | 24 | 0.110 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 86 | 0.110 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 200 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 8 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 111 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 633 | 0.100 |
Why?
|
| Neck | 1 | 2014 | 143 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 48 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 86 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1191 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 169 | 0.100 |
Why?
|
| Adolescent | 7 | 2024 | 20547 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 399 | 0.090 |
Why?
|
| Audiometry | 1 | 2011 | 23 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2011 | 78 | 0.090 |
Why?
|
| Ataxia | 2 | 2022 | 177 | 0.090 |
Why?
|
| Cochlear Implantation | 1 | 2011 | 52 | 0.080 |
Why?
|
| Melanoma | 1 | 2018 | 953 | 0.080 |
Why?
|
| Survivors | 2 | 2022 | 358 | 0.080 |
Why?
|
| Risk Factors | 2 | 2015 | 10954 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2011 | 209 | 0.080 |
Why?
|
| Organometallic Compounds | 2 | 2013 | 106 | 0.080 |
Why?
|
| Cytokines | 1 | 2015 | 1378 | 0.070 |
Why?
|
| Syndrome | 1 | 2011 | 1174 | 0.070 |
Why?
|
| United States | 5 | 2021 | 11723 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2011 | 896 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 3416 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 22 | 0.050 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 18 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2015 | 6582 | 0.050 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2003 | 4 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 49 | 0.050 |
Why?
|
| Joint Diseases | 1 | 2003 | 34 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 38 | 0.050 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 29 | 0.050 |
Why?
|
| Streptococcus gallolyticus | 1 | 2022 | 3 | 0.050 |
Why?
|
| Gadolinium | 1 | 2003 | 117 | 0.050 |
Why?
|
| Streptococcus | 1 | 2022 | 63 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2022 | 72 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 98 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2022 | 63 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 152 | 0.050 |
Why?
|
| Encephalitis | 1 | 2023 | 122 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2023 | 275 | 0.050 |
Why?
|
| Penicillins | 1 | 2022 | 153 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2020 | 37 | 0.040 |
Why?
|
| Gestational Age | 1 | 2024 | 1230 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 62 | 0.040 |
Why?
|
| Biological Factors | 1 | 2020 | 27 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 27 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 55 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 46 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 78 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2003 | 386 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 155 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 110 | 0.040 |
Why?
|
| Workplace | 1 | 2020 | 81 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 441 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 376 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 992 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2138 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 57 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 94 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 467 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 2018 | 11 | 0.040 |
Why?
|
| Adult | 4 | 2023 | 31648 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 285 | 0.040 |
Why?
|
| Family | 1 | 2021 | 593 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 334 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 674 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1166 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 259 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 542 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 420 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 818 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1163 | 0.030 |
Why?
|
| Mitochondria | 1 | 2022 | 755 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 555 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 216 | 0.030 |
Why?
|
| Suture Anchors | 1 | 2014 | 3 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5439 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 13099 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 601 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 250 | 0.030 |
Why?
|
| Optic Disk | 1 | 2014 | 49 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 3664 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 309 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 238 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2246 | 0.030 |
Why?
|
| Meglumine | 1 | 2013 | 16 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 36 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2014 | 116 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 443 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 663 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5199 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2631 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2288 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3043 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3417 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 28952 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 7137 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21479 | 0.010 |
Why?
|